Activity of Aztreonam-Avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa Causing Infections in Immunosuppressed Patients from United States Medical Centers (2019–2024)
Activity of Aztreonam-Avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa Causing Infections in Immunosuppressed Patients from United States Medical Centers (2019–2024). Lead author: Helio S. Sader, presented at IDWeek 2025, Oct 21, Atlanta, GA, USA
Poster #P1315
